Table 2.
Variables Associated With TT at Baseline and Adverse Outcomes (Univariable Analysis)
| Na | TT OR (95% CI) |
VTE HR (95% CI) |
MB HR (95% CI) |
Mortality HR (95% CI) | |
|---|---|---|---|---|---|
| Age, y | 647 | 1.02 (0.99-1.04) | 0.99 (0.96-1.02) | 1.02 (0.99-1.05) | 1.01 (1.00-1.03) |
| Sex (male vs female) | 647 | 1.26 (0.78-2.03) | 1.45 (0.68-3.08) | 1.48 (0.75-2.92) | 1.14 (0.78-1.65) |
| Histological type (clear cell vs nonclear cell) | 620 | 1.58 (0.90-2.77) | 1.11 (0.50-2.48) | 1.76 (0.78-3.96) | 0.68 (0.47-0.99) |
| Fuhrman grade (3-4 vs 1-2) | 469 | 5.54 (3.14-9.76) | 1.48 (0.66-3.36) | 1.63 (0.79-3.36) | 2.92 (1.80-4.75) |
| Karnofsky score (<80% vs ≥80%) | 547 | 2.45 (1.43-4.22) | 2.76 (1.34-5.69) | 3.01 (1.53-5.92) | 5.47 (3.73-8.04) |
| Distant metastases (yes vs no) | 647 | 3.01 (1.92-4.72) | 2.56 (1.32-4.96) | 2.12 (1.16-3.86) | 5.82 (4.10-8.27) |
a
Number of patients with known value for corresponding variable.